Lee Seok Woo, a scientist at Nanyang Technological University’s School of Electrical and Electronic Engineering, drew inspiration from a scene in a “Mission Impossible” movie to develop batteries for smart contact lenses. His expertise in battery components led him to realize that safe and compact batteries would be essential for advancing wearable technology. Given the… Continue reading Scientists develop ultra-thin battery for smart contact lenses that could be charged by tears

The safety of sugar substitutes, particularly xylitol, has been brought into question once again by researchers at the Cleveland Clinic. Their study, published in the European Heart Journal, associates xylitol consumption with an increased risk of heart attack, stroke, or cardiovascular-related deaths. Xylitol, a sugar alcohol, is commonly used as a low-calorie sugar substitute in… Continue reading Common sugar substitute linked to increased risk of heart attack and stroke

A recent study conducted by researchers at the German Aerospace Center’s Institute of Aerospace Medicine and Aachen University has shed light on the potential health risks associated with consuming alcohol during long-haul flights. Traditionally, many passengers indulge in alcohol before settling in for a nap, yet this habit may pose significant challenges to the cardiovascular… Continue reading Drinking alcohol before sleeping on flights presents health risk, study finds

Sword Health, a company offering digital tools for pain management, introduced Phoenix, a new AI solution designed to enhance the virtual physical therapy experience. Launched in 2015, Sword aims to provide home-based pain management solutions to avoid unnecessary surgeries and opioid use. While AI has always been integrated into their products, Phoenix offers a more… Continue reading Medical startup Sword Health announces AI that patients can talk to

Moderna and Merck have presented promising data at the American Society of Clinical Oncology annual meeting regarding their experimental vaccine, administered alongside Merck’s Keytruda therapy, to patients with advanced melanoma, a deadly form of skin cancer. The three-year data reflects substantial improvements in survival rates and long-term efficacy compared to patients receiving Keytruda alone. Notably,… Continue reading Moderna, Merck say vaccine improved survival in patients with deadly skin cancer

SUNNYVALE, Calif., June 3, 2024 /CNW/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces a brokered private placement offering (the “Offering“) of up to 30,000,000 units (“Units“) of Willow at an issue price of C$0.10 per Unit (the… Continue reading WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION

Pfizer’s drug for advanced lung cancer, Lorbrena, has shown promising long-term results in a late-stage trial, potentially positioning it as the new standard treatment for the condition. Lorbrena, already approved for treating adults with a specific gene mutation, demonstrated prolonged progression-free survival and reduced the risk of brain metastases. Despite only 5% of non-small cell… Continue reading Pfizer’s drug for advanced lung cancer shows promising long-term trial results

The Food and Drug Administration (FDA) granted approval for Moderna’s vaccine against respiratory syncytial virus (RSV) for adults aged 60 and above, marking the company’s second product entering the U.S. market. This approval arrives as Moderna seeks diversification amidst declining demand for its Covid vaccine, its sole commercially available product. Based on late-stage trials targeting… Continue reading FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product

L’Oreal is pioneering the development of synthetic skin that aims to mimic the sensation of human touch, presenting a groundbreaking application of bioprinting technology. Demonstrated at the Viva Technology conference in Paris, the company showcased its advancements in 3D printing humanlike skin, emphasizing its use for testing cosmetics without resorting to animal trials. Having ceased… Continue reading L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’

Artificial intelligence (AI) for cancer screening has seen rapid advancements, but many new AI programs are not covered by Medicare or private insurers, posing significant challenges for companies aiming to increase adoption and for patients who could benefit from this technology. According to Brittany Berry-Pusey, CEO of AI screening startup Avenda Health, it can take… Continue reading AI cancer screening programs are booming, but you’ll likely have to pay for them yourself

The article explores the challenges faced by in-store healthcare clinics, exemplified by the recent closures of Walmart’s 51 full-service healthcare centers and Walgreens’ announcement to close 160 VillageMD locations. Despite early promises of convenience, these clinics have struggled to deliver sustainable profits. Retail giants like CVS, with over 1,100 MinuteClinic locations, have also faced clinic… Continue reading Why Walmart, Walgreens, CVS retail health clinic experiment is struggling

Walgreens has declared its commitment to easing financial burdens for consumers by slashing prices on approximately 1,300 items as part of its “summer of savings” initiative, responding to the ongoing struggles faced by shoppers amidst elevated inflation rates. Tracey D. Brown, Walgreens EVP, President of Retail, and Chief Customer Officer, emphasized the company’s dedication to… Continue reading Walgreens announces price cuts on 1,300 items amid ongoing consumer spending fatigue